| Novartis India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 0.02 | 0.03 | 0.06 | 0.09 | 0.05 |
| Long Term Debt-Equity Ratio | 0.01 | 0.02 | 0.05 | 0.07 | 0.04 |
| Current Ratio | 4.29 | 3.75 | 3.97 | 4.06 | 3.99 |
| Fixed Assets | 15.47 | 12.90 | 9.03 | 5.68 | 9.77 |
| Inventory | 7.37 | 7.40 | 9.27 | 8.51 | 8.94 |
| Debtors | 9.45 | 10.25 | 11.69 | 11.89 | 12.81 |
| Interest Cover Ratio | 83.44 | 66.93 | 9.39 | 6.21 | 5.48 |
| PBIDTM (%) | 34.60 | 29.79 | 11.30 | 13.20 | 9.04 |
| PBITM (%) | 33.89 | 28.33 | 9.32 | 10.52 | 6.58 |
| PBDTM (%) | 34.20 | 29.37 | 10.31 | 11.50 | 7.84 |
| CPM (%) | 23.93 | 26.46 | 10.40 | 7.29 | 4.36 |
| APATM (%) | 23.22 | 25.00 | 8.42 | 4.61 | 1.89 |
| ROCE (%) | 15.57 | 14.88 | 5.66 | 5.57 | 4.24 |
| RONW (%) | 11.21 | 14.09 | 5.84 | 2.92 | 1.36 |